Cancer data in Australia

Web report

Last updated: 08 Jun 2021

Topic: Cancer

AIHW

Australian Institute of Health and Welfare 2021. Cancer data in Australia. Cat. no. CAN 122. Canberra: AIHW. Viewed 02 August 2021, https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia

APA

Australian Institute of Health and Welfare. (2021). Cancer data in Australia. Retrieved from https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia

MLA

Cancer data in Australia. Australian Institute of Health and Welfare, 08 June 2021, https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia

Vancouver

Australian Institute of Health and Welfare. Cancer data in Australia [Internet]. Canberra: Australian Institute of Health and Welfare, 2021 [cited 2021 Aug. 2]. Available from: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia

Harvard

Australian Institute of Health and Welfare (AIHW) 2021, Cancer data in Australia, viewed 2 August 2021, https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia

PDF | 3.3Mb

Save web report

Enter the email address where you would like the PDF sent. This address will not be used for any other purpose.

This report provides cancer statistics and data visualisations to inform understandings of cancer in Australia and how rates have been changing over time. The report includes a range of statistics on cancer survival, incidence, mortality and risk for over 70 different cancers with data spanning back to 1982 for cancer incidence and 1971 for cancer mortality.

Cat. no: CAN 122

Findings from this report:

It has been estimated that 2,300 sarcoma cases will be diagnosed in 2021
It has been estimated that 49,000 people will die from cancer in 2021
It has been estimated that 18,000 blood cancer cases will be diagnosed in 2021
It has been estimated that 151,000 new cancer cases will be diagnosed in 2021

Cancer rankings data visualisation

The cancer rankings data visualisation provides the top 20 cancers diagnosed and the leading 20 cancers causing death between 1982 and 2021. The rankings are available by sex and age group (including all ages) and can be presented as counts or rates.

Two rankings tables are provided to allow comparisons to be made. Help with terms, and information about the data, is available by placing the mouse pointer over the icons found near the top of the page.

Please note that the 2021 release of CdiA ranks by all age and 20-year age groups. The previous release provided rankings by 5-year age groups. Rankings for different age groups may be constructed from cancer incidence and mortality by age Excel workbooks.

Cancer incidence and mortality data is available as supplementary tables.

References Expand

ABS (Australian Bureau of Statistics) 2018. Population projections, Australia, 2017 (base) – 2066. ABS cat. no. 3222.0. Canberra: ABS.

AIHW (Australian Institute of Health and Welfare) 2019. BreastScreen Australia monitoring report 2018. Cancer series no.127. Cat no. CAN128. Canberra: AIHW

Al-Marhoon M, Osman A, Kamal M and Shokier A 2011. Incidental vs symptomatic renal tumours: Survival outcomes. Arab Journal of Urology 9(1): 17–21.

Brenner H and Gefeller O 1996. An alternative approach to monitoring cancer patient survival. Cancer78:2004–10.

Dickman PW 2004. Estimating and modelling relative survival using SAS. Stockholm: Karolinska Institutet. Viewed 26 May 2020.

Ederer F & Heise H 1959. Instructions to IBM 650 programmers in processing survival computations. Methodological note.

Greenwood M 1926. The errors of sampling of the survivorship table. Reports on public health and medical subjects. Vol 33. London: Her Majesty’s Stationery Office.

Jensen O, Parkin D, MacLennan R, Muir C & Skeet R (eds) 1991. Cancer registration: principles and methods. IARC scientific publications no. 95. Lyon: IARC.

Luke C, Tracey E, Stapleton A and Roder D 2010. Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for cancer research and cancer control. Internal Medicine Journal 40:357–62.

Qaseem A, Usman N, Jayaraj J S, et al. (September 02, 2019) Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site. Cureus 11(9): e5552. doi:10.7759/cureus.5552

Skuladottir H & Olsen JH 2003. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. Journal of Clinical Oncology 21(16):3035–40.

Smith D Supramaniam R, Marshall V and Armstrong B 2008. Prostate cancer and prostate specific antigen testing in New South Wales. Medical Journal of Australia 189(6): 315–18.

Vaccarella S, Franceschi S, Bray F, Wild C, Plummer M and Dal Maso L 2016. The increase in thyroid cancer may be due to an increase in medical surveillance and the introduction of new diagnostic techniques, such as neck ultrasonography. The New England Journal of Medicine 375: 614–17.

Find reports & data by topic

Featured

Cancer data in Australia

Citation

AIHW

APA

MLA

Vancouver

Harvard

Cancer rankings data visualisation

AIHW

Connect with us

Feedback